These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6229052)

  • 41. Effect of time on vascular prostheses' susceptibility to infection of bacteremic origin.
    Swanson RJ; Moore WS; Campagna G
    Surg Forum; 1973; 24():28-9. PubMed ID: 4806008
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experimental study on the prevention of vascular prosthetic infection with an antibiotic-bonded dacron graft].
    Yu WP; Jing ZP; Bao JM; Zhao ZQ; Zhao J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):348-9. PubMed ID: 15854516
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro and in vivo characterization of a silk fibroin-coated polyester vascular prosthesis.
    Huang F; Sun L; Zheng J
    Artif Organs; 2008 Dec; 32(12):932-41. PubMed ID: 19133021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Re: Efficacy of silver in preventing bacterial infection of vascular dacron graft material.
    O'Connor SA
    Eur J Vasc Endovasc Surg; 2004 May; 27(5):565. PubMed ID: 15080881
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of dacron vascular prosthesis impregnated with salts of silver, in treatment of extraanatomical axilla-femoral by-pass's infection. Infections in vascular surgery.
    Kowalik Z; Kucharski A; Hobot J
    Polim Med; 2002; 32(1-2):80-4. PubMed ID: 12391784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function.
    Malone JM; Moore WS; Campagna G; Bean B
    Surgery; 1975 Aug; 78(2):211-6. PubMed ID: 125460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arteries from human beings are less infectible by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model.
    Koskas F; Goëau-Brissonnière O; Nicolas MH; Bacourt F; Kieffer E
    J Vasc Surg; 1996 Mar; 23(3):472-6. PubMed ID: 8601890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late bacteremic graft infection.
    Ricci MA
    Ann Vasc Surg; 1991 May; 5(3):311. PubMed ID: 1829624
    [No Abstract]   [Full Text] [Related]  

  • 49. Infection of the well-incorporated dacron graft caused by septicemia.
    Humpert EL; Quinn EL; Dienst SG; Szilagyi DE
    Surg Forum; 1972; 23(0):234-6. PubMed ID: 4671085
    [No Abstract]   [Full Text] [Related]  

  • 50. The biologic fate of Dacron double velour vascular prostheses--a clinicopathological study.
    Sato O; Tada Y; Takagi A
    Jpn J Surg; 1989 May; 19(3):301-11. PubMed ID: 2528648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A passive system using rifampin to create an infection-resistant vascular prosthesis.
    Powell TW; Burnham SJ; Johnson G
    Surgery; 1983 Nov; 94(5):765-9. PubMed ID: 6415831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dacron velour vascular prosthesis for hemodialysis.
    Dunn I; Frumkin E; Forte R; Requena R; Levowitz BS
    Proc Clin Dial Transplant Forum; 1972; 2():85. PubMed ID: 4283131
    [No Abstract]   [Full Text] [Related]  

  • 53. Species differences in the clearance of Staphylococcus aureus bacteremia.
    Ricci MA; Mehran R; Christou NV; Mohamed F; Graham AM; Symes JF
    J Invest Surg; 1991; 4(1):53-8. PubMed ID: 1863588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The acute phase response following implantation of triclosan-bonded vascular prostheses.
    Hernandez-Richter TM; Wichmann MW; Schrödl W; Angele MK; Heinritzi K; Schildberg FW
    Clin Exp Med; 2001 Mar; 1(1):35-41. PubMed ID: 11467400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Characteristics of take of vascular prostheses with silver thread].
    Revzis MG; Stepanov GA
    Khirurgiia (Mosk); 1969 Jun; 45(6):12-5. PubMed ID: 4899190
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of three techniques to quantify vascular ingrowth into Dacron velour.
    Estridge TD; Feldman DS
    J Invest Surg; 1988; 1(4):309-19. PubMed ID: 2978985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of infectibility of vascular prosthetic materials by quantitation of median infective dose.
    Bennion RS; Williams RA; Wilson SE
    Surgery; 1984 Jan; 95(1):22-6. PubMed ID: 6229052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
    Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
    Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
    Yasim A; Gul M; Ciralik H; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo testing of an infection-resistant vascular graft material.
    Ozaki CK; Phaneuf MD; Bide MJ; Quist WC; Alessi JM; LoGerfo FW
    J Surg Res; 1993 Nov; 55(5):543-7. PubMed ID: 8231173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.